Last reviewed · How we verify
Jitongning tablets
Jitongning tablets work by improving blood circulation and reducing pain through traditional Chinese medicine principles, likely by promoting qi and blood flow.
Jitongning tablets work by improving blood circulation and reducing pain through traditional Chinese medicine principles, likely by promoting qi and blood flow. Used for Pain relief and circulatory dysfunction (specific indications in Phase 3 development unclear).
At a glance
| Generic name | Jitongning tablets |
|---|---|
| Sponsor | Tasly Pharmaceutical Group Co., Ltd |
| Modality | Small molecule |
| Therapeutic area | Pain Management / Traditional Chinese Medicine |
| Phase | Phase 3 |
Mechanism of action
Jitongning is a traditional Chinese medicine formulation designed to address pain and circulatory dysfunction. The tablet formulation combines herbal ingredients intended to invigorate blood circulation, remove blood stasis, and alleviate pain associated with various conditions. The exact molecular mechanisms are not well-characterized in Western pharmacological terms.
Approved indications
- Pain relief and circulatory dysfunction (specific indications in Phase 3 development unclear)
Common side effects
Key clinical trials
- A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo (PHASE3)
- Study of Jitongning Tablet to Treat Spondyloarthritis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Jitongning tablets CI brief — competitive landscape report
- Jitongning tablets updates RSS · CI watch RSS
- Tasly Pharmaceutical Group Co., Ltd portfolio CI